No Data
No Data
12 Health Care Stocks Moving In Tuesday's After-Market Session
Myriad Genetics Reports Q1 Adjusted EPS (3c), Consensus (5c)
Express News | Myriad Genetics Inc Outlook FY 2025 Rev $807 Mln - $823 Mln
Express News | Myriad Genetics Lowers FY2025 Adj EPS Guidance From $0.07-$0.11 to $(0.02)-$0.02 Vs $0.08 Est; Lowers FY2025 Sales Guidance From $840.00M-$860.00M to $807.00M-$823.00M Vs $844.87M Est
Myriad Genetics | 8-K: Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
Earnings Flash (MYGN) Myriad Genetics Posts Q1 Adjusted EPS $-0.03, Vs. FactSet Est of $-0.05